Previous study has demonstrated that the downregulation of PRMT1 or inhibition of its enzymatic activity in the DSS-induced Apcmin/+ CRC model resulted in a delay in CRC progression [29]. The gene discussed is PRMT1; the disease is colorectal carcinoma.